The Sell-Off Wasn't Failure. It Was Overdue.

Fans want to talk about heart and belief. I want to talk about run prevention, because that is what killed this team's season, and it is fixable if the front office stays honest about the diagnosis. A 34-47 first half and a midseason managerial change do not happen to a $330 million roster by accident. They happen because the structural problems the front office itself flagged last winter — pitching depth and infield defense — never actually got solved.

The Diagnosis Was Right. The Fix Wasn't Big Enough.

Give David Stearns credit: he correctly named pitching and defense, not offense, as the issues last offseason. But naming a problem is not solving it. The rotation still leaned on bounce-back bets — Sean Manaea, Kodai Senga — instead of a true frontline starter, and by midseason the bullpen had turned over almost entirely from the year before. When Carlos Mendoza was fired in June with the club sitting fifth in the division, it was never really about the manager. It was about a roster asked to overperform its true talent level for a second straight year.

COACH'S NOTE: Firing a manager at 34-47 buys you a news cycle. It does not fix a pitching staff that was never deep enough to survive one injury, let alone the wave that hit this year.

Why the Sell-Off Was the Right Call

I know it is hard for a fan base that just signed Juan Soto to watch Freddy Peralta, Clay Holmes, Luke Weaver and A.J. Minter all get moved. Evaluate it as a personnel man instead of a fan: none of those four were part of a realistic contention window once the team fell fifteen games back in late June. Trading impending free agents for controllable young talent while they still carry value is the textbook correct move, not a surrender.

• Jefferson Rojas (SS/3B, from the Cubs) instantly became the system's No. 1 prospect and now ranks inside the game's top 80 overall — a legitimate long-term answer at a premium position.
• Sammy Stafura (via the Luke Weaver deal) landed at No. 3 in the updated system rankings almost immediately — a rare return for a rental-caliber arm.
• Seven of the twelve prospects acquired at the deadline landed inside the revamped top 20, an unusually strong haul for half a season of selling.

That is not rebuilding for its own sake. That is restocking a system thin enough behind Jonah Tong and Jonathan Santucci that one bad rotation year could have set the organization back three seasons.

What Still Needs to Get Fixed

The deadline helped the farm, not the major-league roster. The two things that sank the first half remain: a bullpen that lost the majority of its 2025 contributors, Edwin Diaz included, and infield defense that graded near the bottom of the league for most of the year. Andy Green steadying the ship down the stretch is a fine story. The real offseason job is a genuine bullpen anchor and settling second and third base with players who catch the ball, not just hit it.

The Arms Are Coming — On Schedule, Not Ahead of It

The good news is real: this system is no longer short on pitching. Tong, Santucci and now Stafura give this club a pipeline that should start supplying rotation help by 2027 without overpaying in free agency. Rojas gives them a potential long-term shortstop or third baseman who will not have to be traded away for pitching later. That is a healthier place than most 34-47 teams find themselves in August.

2027 Names to Watch

• Jefferson Rojas, SS/3B — the system's top prospect after arriving from the Cubs; potential everyday shortstop as soon as 2027.
• Jonah Tong, RHP — the most polished arm in the system and a candidate to anchor a future rotation.
• Jonathan Santucci, LHP — the left-handed complement to Tong, with a major-league ETA already attached.
• Sammy Stafura, SS — the headline return from the Weaver trade and one of the fastest-rising names in the system.

None of this excuses a first half that fell apart in real time. But a front office that corrects its own course, sells at the right moment instead of holding too long, and walks away with this much young talent has done more good work than a 34-47 record suggests. Spend the winter on a bullpen and an infield glove — not another bat.

This piece reflects the author's independent analysis and personal opinion on the New York Mets' 2026 season. It is intended as commentary, not an official team evaluation or prediction.